Pharma Journalist 9038 posts 0 comments

Eli Lilly and Company announced an initial agreement with the U.S. government to supply 300,000 vials of bamlanivimab (LY-CoV555) 700 mg, an investigational neutralizing antibody, for…
Read More...

Novartis and Molecular Partners AG announced a collaboration in the form of an option and license agreement to develop, manufacture and commercialize Molecular Partners’ anti-COVID-19…
Read More...

CStone Pharmaceuticals announced a licensing agreement with LegoChem Biosciences, Inc. for the development and commercialization of LCB71, a potential first-in-class/best-in-class…
Read More...

Releviate Therapeutics, a bio-pharmaceutical company addressing the needs of patients suffering from chronic pain, signs an exclusive license for two patent pending human monoclonal…
Read More...

insitro, a machine-learning driven drug discovery and development company, today announced that it has entered into a five-year, discovery collaboration with Bristol Myers Squibb (NYSE:…
Read More...

Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable…
Read More...

Apellis Pharmaceuticals, Inc. and Swedish Orphan Biovitrum AB (publ) announced a strategic collaboration to accelerate the advancement of systemic pegcetacoplan, a targeted C3 therapy,…
Read More...

Kala Pharmaceuticals, Inc. a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye announced that the…
Read More...

Histogen Inc. a clinical-stage therapeutics company focused on developing potential first-in-class therapeutics that ignite the body’s natural process to repair and maintain healthy…
Read More...

SFJ Pharmaceuticals is pleased to note that its partner Apellis Pharmaceuticals Inc. and Swedish Orphan Biovitrum AB announced a strategic collaboration to accelerate the advancement of…
Read More...